KEGG   Lutra lutra (Eurasian river otter): 125103142
Entry
125103142         CDS       T08100                                 
Name
(RefSeq) tumor necrosis factor isoform X1
  KO
K03156  tumor necrosis factor superfamily, member 2
Organism
llv  Lutra lutra (Eurasian river otter)
Pathway
llv01523  Antifolate resistance
llv04010  MAPK signaling pathway
llv04060  Cytokine-cytokine receptor interaction
llv04061  Viral protein interaction with cytokine and cytokine receptor
llv04064  NF-kappa B signaling pathway
llv04071  Sphingolipid signaling pathway
llv04150  mTOR signaling pathway
llv04210  Apoptosis
llv04217  Necroptosis
llv04350  TGF-beta signaling pathway
llv04380  Osteoclast differentiation
llv04612  Antigen processing and presentation
llv04620  Toll-like receptor signaling pathway
llv04621  NOD-like receptor signaling pathway
llv04622  RIG-I-like receptor signaling pathway
llv04625  C-type lectin receptor signaling pathway
llv04640  Hematopoietic cell lineage
llv04650  Natural killer cell mediated cytotoxicity
llv04657  IL-17 signaling pathway
llv04660  T cell receptor signaling pathway
llv04664  Fc epsilon RI signaling pathway
llv04668  TNF signaling pathway
llv04920  Adipocytokine signaling pathway
llv04930  Type II diabetes mellitus
llv04931  Insulin resistance
llv04932  Non-alcoholic fatty liver disease
llv04933  AGE-RAGE signaling pathway in diabetic complications
llv04936  Alcoholic liver disease
llv04940  Type I diabetes mellitus
llv05010  Alzheimer disease
llv05014  Amyotrophic lateral sclerosis
llv05020  Prion disease
llv05022  Pathways of neurodegeneration - multiple diseases
llv05132  Salmonella infection
llv05133  Pertussis
llv05134  Legionellosis
llv05135  Yersinia infection
llv05140  Leishmaniasis
llv05142  Chagas disease
llv05143  African trypanosomiasis
llv05144  Malaria
llv05145  Toxoplasmosis
llv05146  Amoebiasis
llv05152  Tuberculosis
llv05160  Hepatitis C
llv05161  Hepatitis B
llv05163  Human cytomegalovirus infection
llv05164  Influenza A
llv05165  Human papillomavirus infection
llv05166  Human T-cell leukemia virus 1 infection
llv05168  Herpes simplex virus 1 infection
llv05169  Epstein-Barr virus infection
llv05170  Human immunodeficiency virus 1 infection
llv05171  Coronavirus disease - COVID-19
llv05205  Proteoglycans in cancer
llv05310  Asthma
llv05321  Inflammatory bowel disease
llv05322  Systemic lupus erythematosus
llv05323  Rheumatoid arthritis
llv05330  Allograft rejection
llv05332  Graft-versus-host disease
llv05410  Hypertrophic cardiomyopathy
llv05414  Dilated cardiomyopathy
llv05417  Lipid and atherosclerosis
llv05418  Fluid shear stress and atherosclerosis
Brite
KEGG Orthology (KO) [BR:llv00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04010 MAPK signaling pathway
    125103142
   04350 TGF-beta signaling pathway
    125103142
   04064 NF-kappa B signaling pathway
    125103142
   04668 TNF signaling pathway
    125103142
   04071 Sphingolipid signaling pathway
    125103142
   04150 mTOR signaling pathway
    125103142
  09133 Signaling molecules and interaction
   04060 Cytokine-cytokine receptor interaction
    125103142
   04061 Viral protein interaction with cytokine and cytokine receptor
    125103142
 09140 Cellular Processes
  09143 Cell growth and death
   04210 Apoptosis
    125103142
   04217 Necroptosis
    125103142
 09150 Organismal Systems
  09151 Immune system
   04640 Hematopoietic cell lineage
    125103142
   04620 Toll-like receptor signaling pathway
    125103142
   04621 NOD-like receptor signaling pathway
    125103142
   04622 RIG-I-like receptor signaling pathway
    125103142
   04625 C-type lectin receptor signaling pathway
    125103142
   04650 Natural killer cell mediated cytotoxicity
    125103142
   04612 Antigen processing and presentation
    125103142
   04660 T cell receptor signaling pathway
    125103142
   04657 IL-17 signaling pathway
    125103142
   04664 Fc epsilon RI signaling pathway
    125103142
  09152 Endocrine system
   04920 Adipocytokine signaling pathway
    125103142
  09158 Development and regeneration
   04380 Osteoclast differentiation
    125103142
 09160 Human Diseases
  09161 Cancer: overview
   05205 Proteoglycans in cancer
    125103142
  09172 Infectious disease: viral
   05166 Human T-cell leukemia virus 1 infection
    125103142
   05170 Human immunodeficiency virus 1 infection
    125103142
   05161 Hepatitis B
    125103142
   05160 Hepatitis C
    125103142
   05171 Coronavirus disease - COVID-19
    125103142
   05164 Influenza A
    125103142
   05168 Herpes simplex virus 1 infection
    125103142
   05163 Human cytomegalovirus infection
    125103142
   05169 Epstein-Barr virus infection
    125103142
   05165 Human papillomavirus infection
    125103142
  09171 Infectious disease: bacterial
   05132 Salmonella infection
    125103142
   05135 Yersinia infection
    125103142
   05133 Pertussis
    125103142
   05134 Legionellosis
    125103142
   05152 Tuberculosis
    125103142
  09174 Infectious disease: parasitic
   05146 Amoebiasis
    125103142
   05144 Malaria
    125103142
   05145 Toxoplasmosis
    125103142
   05140 Leishmaniasis
    125103142
   05142 Chagas disease
    125103142
   05143 African trypanosomiasis
    125103142
  09163 Immune disease
   05310 Asthma
    125103142
   05322 Systemic lupus erythematosus
    125103142
   05323 Rheumatoid arthritis
    125103142
   05321 Inflammatory bowel disease
    125103142
   05330 Allograft rejection
    125103142
   05332 Graft-versus-host disease
    125103142
  09164 Neurodegenerative disease
   05010 Alzheimer disease
    125103142
   05014 Amyotrophic lateral sclerosis
    125103142
   05020 Prion disease
    125103142
   05022 Pathways of neurodegeneration - multiple diseases
    125103142
  09166 Cardiovascular disease
   05417 Lipid and atherosclerosis
    125103142
   05418 Fluid shear stress and atherosclerosis
    125103142
   05410 Hypertrophic cardiomyopathy
    125103142
   05414 Dilated cardiomyopathy
    125103142
  09167 Endocrine and metabolic disease
   04930 Type II diabetes mellitus
    125103142
   04940 Type I diabetes mellitus
    125103142
   04936 Alcoholic liver disease
    125103142
   04932 Non-alcoholic fatty liver disease
    125103142
   04931 Insulin resistance
    125103142
   04933 AGE-RAGE signaling pathway in diabetic complications
    125103142
  09176 Drug resistance: antineoplastic
   01523 Antifolate resistance
    125103142
 09180 Brite Hierarchies
  09183 Protein families: signaling and cellular processes
   04052 Cytokines and neuropeptides [BR:llv04052]
    125103142
   00536 Glycosaminoglycan binding proteins [BR:llv00536]
    125103142
Cytokines and neuropeptides [BR:llv04052]
 Cytokines
  Tumor necrosis fators
   125103142
Glycosaminoglycan binding proteins [BR:llv00536]
 Heparan sulfate / Heparin
  Cytokines
   125103142
SSDB
Motif
Pfam: TNF
Other DBs
NCBI-GeneID: 125103142
NCBI-ProteinID: XP_047590937
LinkDB
Position
6:29746640..29749303
AA seq 234 aa
MSTESMIRDVELGEEALPKKAGSPKGSRRCWCLSLFSFLLVAGATTLFCLLHFGVIGPQR
EEQLPDGLQLIKPLAQTVKSSSRTPSDKPVAHVVANPEAEGQLQWLSRRANALLANGVEL
TDNQLIVPSDGLYLIYSQVLFKGQGCSSTNVLLTHTISRFAVSYQTKVNLLSAIKSPCQR
ETPEGTEAKPWYEPIYLGGVFQLEKGDRLSAEINLPDYLDFAESGQVYFGIIAL
NT seq 705 nt   +upstreamnt  +downstreamnt
atgagcactgaaagcatgatccgggacgtggagctgggcgaggaggcactccccaagaag
gcagggtcccccaagggctcccgaaggtgctggtgcctcagcctcttctccttcctcctc
gtcgcaggagccaccacactcttctgcctgctgcactttggagtgatcggcccccagagg
gaagagcagctcccagatggcctccaactaatcaaacctctggcccagacagtcaaatca
tcttctcgaactccaagtgacaagcccgtagctcatgttgtagcaaaccctgaagctgag
gggcaactccaatggctgagccggcgtgccaatgccctcctggccaatggtgtggagctg
acagacaaccagctaatagtgccatcagacgggctgtacctcatctactcccaggtcctc
ttcaagggccaaggatgttcttccaccaatgtgctcctcacccacaccatcagccgcttt
gctgtctcctaccagaccaaggtcaacctcctctctgccatcaagagcccttgccaaagg
gagaccccagagggaactgaggccaagccctggtacgagcccatctacctgggaggggtc
ttccaattggagaagggggatcgactcagcgctgagatcaacctgcctgactatctcgac
tttgccgaatccgggcaggtctactttggaatcattgccctgtga

DBGET integrated database retrieval system